Medical Patent News

RSS

DuPont settles patent case with Bio-Rad Laboratories

DuPont has announced that it has settled patent infringement litigation against Bio-Rad Industries, Inc. of Hercules, Calif.

27 Apr 2007

Avicena files composition of matter patent application for treatment of Parkinson's disease

Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.

27 Apr 2007

PDL BioPharma's European patent claims upheld

PDL BioPharma has announced that the Opposition Division of the European Patent Office decided at an oral proceeding to uphold claims in the company's European Patent No. 0 451 216 ('216 patent) that are virtually identical to the claims remitted to the Opposition Division by the Board of Appeal.

25 Apr 2007

Luminex Corporation licenses cystic fibrosis gene patent from John Hopkins

Luminex Corporation has announced that it has acquired a non-exclusive license from The Johns Hopkins University for the rights to use the university's patented cystic fibrosis genetic markers in the company's molecular diagnostic products sold in the United States.

From Luminex 25 Apr 2007

Novadaq Technologies acquires fluorescence endoscopy patents from Xillix

Novadaq Technologies Inc. has announced that it has entered into an asset purchase agreement to acquire certain business assets of Xillix Technologies Corp., including all of Xillix's intellectual property, certain capital assets and inventory.

24 Apr 2007

Avicena files composition of matter patent application for treatment of Lou Gehrig's disease

Avicena Group has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease), a severe neurodegenerative disease.

24 Apr 2007

Osprey Pharmaceuticals issued 3 U.S. patents

Osprey Pharmaceuticals Limited has announced that it has been granted three patents by the U.S. Patent Office.

17 Apr 2007

Martek receives European patent

Martek Biosciences has announced that the European Patent Office (EPO) has granted another patent to Martek for ARA (arachidonic acid) oil made from Martek's microbial source for use in infant formula.

12 Apr 2007

Synergetics settles patent case

The parties have entered into a Settlement Agreement and a Manufacture and Supply Agreement to resolve both lawsuits and all claims between the parties.

11 Apr 2007

Barr Pharmaceuticals receives Notice of Allowance for Seasonale patent

Barr Pharmaceuticals has announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for the reissuance of U.S. Patent 5,895,032 ('032), relating to Barr's SEASONALE extended-cycle oral contraceptive.

10 Apr 2007

Combination Lyme disease vaccine proteins patented

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and collaborators at Stony Brook University have received U.S. Patent Number 7,179,448 for developing chimeric, or "combination," proteins that may advance the development of vaccines and diagnostic tests for Lyme disease.

9 Apr 2007

Palomar Medical resolves patent issue with Alma Lasers

Palomar Medical Technologies has announced the resolution of its on- going patent infringement and trade dress infringement lawsuit against Alma Lasers, Inc.

4 Apr 2007

Lifeblood Medical receives U.S. patent notice

Lifeblood Medical has announced that it has received a Notice of Allowance from the U.S. Patent Office for its patent application titled, "Composition for Maintaining Organ and Cell Viability."

28 Mar 2007

Microbix granted Canadian patent for vaccine technology

Microbix Biosystems has announced that it has been granted a patent by the Canadian Patent Office for its Vaccine Technology. This technology holds the promise of significantly boosting global production of influenza vaccines.

22 Mar 2007

Penwest confirms action on Oxymorphone patent application

Penwest Pharmaceuticals has confirmed that the U.S. Patent and Trademark Office (PTO) has posted on its website an indication that a final rejection of Penwest's patent application claiming the sustained release formulations of Oxymorphone will be mailed.

15 Mar 2007